Under the intervention of relevant departments, Shuguang Group and Film Group died down for a while.

Although it was calm for a while, everyone could see that it was calm before the storm.

Immediately, a piece of news was revealed, and the Kejin special drug has been approved by the drug regulatory department and has been included in the vigorous support plan.

This news was like igniting a powder keg, and in an instant, the gunpowder between the Dawning Group and the Film Group was ignited.

Shuguang Group has been secretly planning these days, planning and then acting, and finally striving to pass the approval in advance.

In fact, this is not only the credit of Wang Zhen, but also the effect of the gram gold special effect drug is too great, so it has obtained the qualification for priority inspection

Thus more than a month in advance.

In just 40 days now, it has been successfully approved and has received strong support from the state, of course, taking into account the concept of affordable drugs advocated by Shuguang Group.

Otherwise, with this drug, it is enough to make a sky-high price, and it will not be priced at nine yuan a piece now.

This time, the state is determined to vigorously support the development of gramin-specific drugs, stipulating that for every gram-gold special drug produced, a subsidy of 3 cents will be provided.

Don't look at 3 cents is very little, but according to the market demand and the production plan of Shuguang Group, the annual production of at least three billion pieces, which is only domestic.

In addition, three billion foreign ones, one billion a year, according to the support plan, both domestic and foreign ones must be supported, that is to say, at least six billion 3 cents should be subsidized every year.

It is equivalent to a subsidy of 1.8 billion, so is this still a small amount? And the annual production of 6 billion is only the bottom line.

Because about 30 billion special drugs are consumed every year in China, this drug can cure mild patients, and severe patients can only be surgically combined with drugs, which greatly improves the success rate

It's not that this miracle medicine is a panacea for all diseases. No matter how you say it, it is the reason for the small profits and quick turnover of Shuguang Group, which makes many people trust.

This is also the reason why Shuguang Group has developed rapidly in the past 30 years, that is, it has won the hearts of the people.

The film pharmaceutical group is an overseas company, and the drugs it sells are all high-priced drugs, and in the early years, it was developed by selling high-priced drugs.

After the news that the Kejin special drug was approved and received strong support from the state, it immediately caused a huge response.

It was a blessing for the common people, who had finally looked forward to this moment.

It is the first drug that can treat patients with mild symptoms so far, and many patients are looking forward to and even eager for it.

And this is an affordable drug, not an expensive drug, which means that they can afford it, and they don't have to worry about waiting for the aggravation of the disease because they can't afford the expensive drug.

It is indeed a blessing for the common people, but it is not a good thing for the film pharmaceutical group.

The current top management of the film pharmaceutical group has been in a mess, and their market share has gradually decreased in recent years, and no new drugs have been developed.

The reason for this is that the film group does not pay attention to the medical researchers of their group, and even the results of other people's research for many years have to be forcibly taken away.

Even drugs developed by others do not even give the right of authorship to others, and take the ownership into their own hands.

Not only that, but even basic benefits and salaries are repeatedly in arrears, and they are all coming and gone.

Slowly, the medical research base under the film pharmaceutical group has a serious brain drain, except for signing a ten-year or five-year term with them, these professors with a limited term dare not leave because they are facing huge compensation.

The rest of the people continued to flow away, and most of them instead joined the Shuguang Pharmaceutical Group, where well-known professors are still working at the Shuguang Medical Research Base.

Later, slowly, the senior management of the film group realized the seriousness of the matter and wanted to make amends, but it was too late.

These professors are not all for money, they have been able to reach today's status because of their real talents.

To put it bluntly, they are also temperamental and arrogant, and what is usually said is that there is no master here, there is a place to keep the master.

Therefore, the current film medical research base has long since lost the grand occasion of the past, and is already an empty shell.

Now the professors who are forced to stay in the film medical research base have long lost their passion for work, even if the film group has changed a lot now, but for them, they have long lost their sense of belonging to the film medicine group.

Every day in the research base, I have to get by, and I have nothing to do.

Even so, the film pharmaceutical group is still unwilling to let them go, for fear that they will turn around and defect to the Shuguang Medical Research Base.

They are well aware of the attraction of the Dawning Medical Research Base to their professors.

That's why they want to annex the Akegon Medical Research Base now, because the Akegon Medical Research Base is very important to the development of their group.

In fact, the film group is discussing internally whether to abandon the film pharmaceutical group and merge it into other industries. Because businessmen are all about profits, the market share occupied by the film pharmaceutical group has gradually decreased in recent years.

And it has been in the loss year after year, if it weren't for the fact that the film group would have collapsed long ago, the film group would have to subsidize its own profits to the film pharmaceutical group every year.

In the eyes of the senior management of the film group, the film pharmaceutical group has lost its original value, and it is time to abandon it.

But such a big piece of cake in the field of medicine, if they give up, they will also feel unwilling.

It's a pity to abandon it like chicken ribs.

When the film pharmaceutical group proposed to annex the Shuguang pharmaceutical group with the help of the capital of the film group, this made the senior management of the film group shine and felt that this method was very good.

However, they have set a time limit for this task to be completed within this year, otherwise they will no longer provide financial support to the film pharmaceutical group.

Without the financial support of the film group, the film pharmaceutical group would not have survived for three months.

This is the most important reason why Filmin Pharmaceutical Group is so anxious to deal with Shuguang Pharmaceutical Group.

Although the film pharmaceutical group is a subsidiary of the film group, and the top management is a family, why is the film pharmaceutical group so resistant to the decision of the film group.

This is also because of the contradictions within the film group, which is a family business.

The Feilin family itself is a famous family and a famous financial family.

In this kind of wealthy family, internal contradictions and family struggles are very strong.

Intrigue and framing in every possible way, all want to completely master this huge family machine.

It would be impossible without a little skill, and the head of the film group is still the head of the film family.

However, the general manager of the film group is the eldest son of the head of the film family.

The person in charge of the film pharmaceutical group is the grandson of the second master of the film family, film Hegert.

Fillingbult was the younger brother of Filinghegert.

The Filin family is not a family of the same lineage.

Both the main vein and the branch vein are qualified to inherit the position of the head of the family.

As long as there is the blood of the Filin family, they can be eligible.

But even so, the influence of the branch vein is 108,000 miles lower than that of the main vein.

There is no comparison between the branch vein and the main vein, and the most powerful in the main vein now belongs to the main vein of the Feilin family and the second master of the Feilin family.

These two veins are comparable in terms of both the number of people and the family resources they master.

The dispute between the two veins has been going on for a long time, and the original head of the Filin family won the position of head of the family by means of ulterior means.

And the second master of the film family is the one who leads the glory of the film family.

The reason why the Feilin family can be so brilliant is inseparable from the second master of the Feilin family.

If it is said that the head of the Fei Lin family is the most powerful of the Fei Lin family.

Then the second master of the Feilin family is the hope of the Feilin family and the sun of their family.

This is the current situation of the Filin family.

They are incompatible with each other.